SCHEMBL2562267

SCHEMBL2562267

NC1CCC[C@@H]1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1670621 1.00
SCHEMBL420637 1.00
SCHEMBL420636 1.00
SCHEMBL85607 1.00
SCHEMBL56195 1.00
SCHEMBL578646 1.00
SCHEMBL5346790 1.00
SCHEMBL7738881 1.00
SCHEMBL30484837 1.00
Hydrochloric Acid SCHEMBL3413778 0.97 PEPD (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240374689-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2024-11-14 US disclosed
US-20230080520-A1 PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2023-03-16 US disclosed
US-11278595-B2 Peptides comprising non-natural amino acids and methods of making and using the same LONGEVITY BIOTECH, INC. (US) 2022-03-22 US disclosed
US-20210205415-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC 2021-07-08 US disclosed
US-20200384085-A1 PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2020-12-10 US disclosed
US-10772934-B2 Highly active polypeptides and methods of making and using the same LONGEVITY BIOTECH, INC. (US) 2020-09-15 US disclosed
US-10543255-B2 Peptides comprising non-natural amino acids and methods of making and using the same LONGEVITY BIOTECH, INC. (US) 2020-01-28 US disclosed
US-20180193423-A1 PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2018-07-12 US disclosed
US-20180193422-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2018-07-12 US disclosed
US-10016409-B2 Method for improving interstitial flow FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE (JP) 2018-07-10 US disclosed
US-20170252318-A1 NOVEL THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE NAGASAKI UNIVERSITY (JP) 2017-09-07 US disclosed
US-9737524-B2 Prophylactic and/or therapeutic agent for mild cognitive impairment FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION (JP) 2017-08-22 US disclosed
US-20160045572-A1 PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2016-02-18 US disclosed
EP-2968469-A2 PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME Longevity Biotech, Inc. (US) 2016-01-20 EP disclosed
US-20160008348-A1 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR MILD COGNITIVE IMPAIRMENT FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION (JP) 2016-01-14 US disclosed
US-20150152084-A1 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR MILD COGNITIVE IMPAIRMENT FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION (JP) 2015-06-04 US disclosed
EP-2862572-A1 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR MILD COGNITIVE IMPAIRMENT Foundation for Biomedical Research and Innovation (JP) 2015-04-22 EP disclosed
WO-2014145718-A2 PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. (US) 2014-09-18 WO disclosed
US-20130096050-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. (US) 2013-04-18 US disclosed
WO-2011133948-A2 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. (US) 2011-10-27 WO disclosed